Cargando…

Opsonic Activity of Conservative Versus Variable Regions of the Group A Streptococcus M Protein

Group A Streptococcus (GAS) and GAS-associated infections are a global challenge, with no licensed GAS vaccine on the market. The GAS M protein is a critical virulence factor in the fight against GAS infection, and it has been a primary target for GAS vaccine development. Measuring functional opsoni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Chuankai, Khalil, Zeinab G., Hussein, Waleed M., Yang, Jieru, Wang, Xiumin, Zhao, Lili, Capon, Robert J., Toth, Istvan, Stephenson, Rachel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349123/ https://www.ncbi.nlm.nih.gov/pubmed/32392777 http://dx.doi.org/10.3390/vaccines8020210

Ejemplares similares

Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus
por: Yang, Jieru, et al.
Publicado: (2021)

Polyacrylate–Peptide Antigen Conjugate as a Single-Dose Oral Vaccine against Group A Streptococcus
por: Faruck, Mohammad Omer, et al.
Publicado: (2020)

Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A Streptococcus
por: Zhao, Lili, et al.
Publicado: (2020)

The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines
por: Yang, Jieru, et al.
Publicado: (2023)

Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2022)

Development of Multilayer Nanoparticles for the Delivery of Peptide-Based Subunit Vaccine against Group A Streptococcus
por: Kiong, Jolynn, et al.
Publicado: (2022)

Lack of Opsonic Antibody Responses to Invasive Infections With Streptococcus dysgalactiae
por: Bläckberg, Anna, et al.
Publicado: (2021)

Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
por: Giebink, G. S., et al.
Publicado: (1978)

Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2019)

Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies
por: Rivera-Hernandez, Tania, et al.
Publicado: (2020)

Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera
Publicado: (1978)

The Opsonic Method of Treatment
Publicado: (1908)

Is Opsonic Treatment Useful in Phthisis?
por: Munro, John M. H.
Publicado: (1908)

The Opsonic Index and Its Utility
Publicado: (1907)

Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances
por: Zhang, Jiahui, et al.
Publicado: (2022)

Advances in Infectious Disease Vaccine Adjuvants
por: Fan, Jingyi, et al.
Publicado: (2022)

A quantitative Streptococcus pyogenes–human protein–protein interaction map reveals localization of opsonizing antibodies
por: Happonen, Lotta, et al.
Publicado: (2019)

AN EXPERIMENTAL STUDY OF OPSONIC IMMUNITY TO STAPHYLOCOCCUS AUREUS
por: Meakins, J. C.
Publicado: (1910)

Chimeric oligosaccharide conjugate induces opsonic antibodies against Streptococcus pneumoniae serotypes 19A and 19F
por: Sanapala, Someswara Rao, et al.
Publicado: (2020)

ON THE NATURE OF THE OPSONIC SUBSTANCES OBNORMAL SERA
por: Zinsser, Hans, et al.
Publicado: (1914)

The Use of the Opsonic Index in the Diagnosis of Tuberculosis
Publicado: (1907)

The Opsonic Index of the Blood and the Treatment of Phthisis
Publicado: (1905)

The Actual Technique of Tuberculo-Opsonic Estimation
Publicado: (1908)

On the Use of the Opsonic Index in the Diagnosis of Tuberculosis
por: Stewart, Ian Struthers, et al.
Publicado: (1907)

Vaccine Therapy and the Opsonic Method of Treatment
Publicado: (1909)

On the Value of the Tuberculo-Opsonic Index in Diagnosis
por: Fraser, Elizabeth T.
Publicado: (1907)

On the Value of the Tuberculo-Opsonic Index in Diagnosis
por: Fraser, Elizabeth T.
Publicado: (1907)

Inhibition of osteoclastogenesis by opsonized Porphyromonas gingivalis
por: Pandruvada, Subramanya N., et al.
Publicado: (2019)

On the Use of the Opsonic Index in the Diagnosis of Tuberculosis
por: Stewart, Ian Struthers, et al.
Publicado: (1907)

The Influence of Alcohol on the Opsonic Power of the Blood
por: Stewart, Chas. E.
Publicado: (1908)

Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci
Publicado: (1984)

Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein
Publicado: (1985)

The Value of Determining the Opsonic Index in the Treatment of Chronic Infections with Vaccines
por: Paullin, J. Edgar
Publicado: (1908)

Microglial responses to amyloid β peptide opsonization and indomethacin treatment
por: Strohmeyer, Ronald, et al.
Publicado: (2005)

IdeS, a secreted proteinase of Streptococcus pyogenes, is bound to a nuclease at the bacterial surface where it inactivates opsonizing IgG antibodies
por: Frick, Inga-Maria, et al.
Publicado: (2023)

Engineered human antibodies for the opsonization and killing of Staphylococcus aureus
por: Chen, Xinhai, et al.
Publicado: (2022)

The Opsonic Theory and the Resulting Method of Treatment of Bacterial Diseases
Publicado: (1907)

Opsonic Researches in Patients Suffering from Streptococcic Wounds
Publicado: (1919)

The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci
Publicado: (1988)

Oral Peptide Vaccine against Hookworm Infection: Correlation of Antibody Titers with Protective Efficacy
por: Shalash, Ahmed O., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ucsikc0pda6k66258st7unmho6